Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, preve...

書誌詳細
主要な著者:	Dockrell, HM, McShane, H
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2022

類似資料

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
著者:: Hazel M. Dockrell, 等
出版事項: (2022-05-01)

Vaccines for tuberculosis
著者:: McShane, H
出版事項: (2013)

Vaccine strategies against tuberculosis
著者:: H McShane
出版事項: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
著者:: McShane, H
出版事項: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
著者:: McShane, H
出版事項: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
著者:: McShane, H
出版事項: (2011)

Tuberculosis vaccines: Progress and challenges
著者:: Checkley, A, 等
出版事項: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
著者:: McShane, H
出版事項: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
著者:: Davenne, T, 等
出版事項: (2016)

Clinical testing of tuberculosis vaccine candidates
著者:: Hatherill, M, 等
出版事項: (2016)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
著者:: Hanekom, W, 等
出版事項: (2008)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
著者:: Vermaak, S, 等
出版事項: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
著者:: Tanner, R, 等
出版事項: (2016)

Why does it take so long? The reasons behind tuberculosis treatment delay in Portugal
著者:: I. Zão, 等
出版事項: (2019-07-01)

Reasons for Taking the COVID-19 Vaccine by US Social Media Users
著者:: Arriel Benis, 等
出版事項: (2021-03-01)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
著者:: Morrison, H, 等
出版事項: (2023)

Human and Bovine Tuberculosis
著者:: McShane, H
出版事項: (2016)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
著者:: Hazel Morrison, 等
出版事項: (2023-05-01)

Vaccination against tuberculosis: how can we better BCG?
著者:: Pitt, J, 等
出版事項: (2013)

Vaccination against tuberculosis: How can we better BCG?
著者:: Pitt, J, 等
出版事項: (2013)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
著者:: Smith, S, 等
出版事項: (2010)

“It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome
著者:: Brown, P, 等
出版事項: (2022)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
著者:: Stylianou, E, 等
出版事項: (2019)

How Did CNBSS Influence Guidelines for So Long and What Can That Teach Us?
著者:: Shushiela Appavoo
出版事項: (2022-05-01)

What makes us more susceptible to false memories in the era of COVID‐19? A focus on vaccines and Green Pass
著者:: Chiara Scuotto, 等
出版事項: (2023-01-01)

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development
著者:: Kaufmann, S, 等
出版事項: (2017)

Long COVID-19 Pathophysiology: What Do We Know So Far?
著者:: Nikolaos-Renatos Tziolos, 等
出版事項: (2023-09-01)

“It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome
著者:: Poppy Brown, 等
出版事項: (2022-01-01)

Vaccine strategies against tuberculosis.
著者:: Mcshane, H
出版事項: (2009)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
著者:: Willem A Hanekom, 等
出版事項: (2008-07-01)

IVM: What are the RCTs Telling Us So Far?
著者:: Johan E.J. SMITZ
出版事項: (2022-09-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
著者:: Hopkins, R, 等
出版事項: (2011)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
著者:: Hanekom, W, 等
出版事項: (2008)

TB vaccine development: where are we and why is it so difficult?
著者:: Wilkie, M, 等
出版事項: (2014)

Controlled human infection models: is it really feasible to give people tuberculosis?
著者:: McShane, H
出版事項: (2020)

Is a human CD8 T-cell vaccine possible, and if so, what would it take? Could a CD8+ T-cell vaccine prevent persistent HIV infection?
著者:: McMichael, A
出版事項: (2017)

Developing an improved vaccine against tuberculosis.
著者:: Mcshane, H
出版事項: (2004)

Local pulmonary immunological biomarkers in tuberculosis
著者:: Morrison, H, 等
出版事項: (2021)

Local Pulmonary Immunological Biomarkers in Tuberculosis
著者:: Hazel Morrison, 等
出版事項: (2021-03-01)

Tuberculosis vaccines in clinical trials.
著者:: Rowland, R, 等
出版事項: (2011)